Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report) CEO Jon Congleton sold 16,229 shares of the company’s stock in a transaction on Friday, June 14th. The stock was sold at an average price of $12.52, for a total transaction of $203,187.08. Following the transaction, the chief executive officer now owns 976,271 shares of the company’s […]
Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Wall Street Breakfast Podcast: Disney Unveils Buyback Return seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Sees Large Decrease in Short Interest theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Mineralys Therapeutics To Participate In The Guggenheim Securities 6Th Annual Biotechnology Conference menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.